Orphan drugs: pricing, reimbursement and patient access

Author： Barak Adam   Nandi Jyoti Shankar  

Publisher： Emerald Group Publishing Ltd

ISSN： 1750-6123

Source： International Journal of Pharmaceutical and Healthcare Marketing, Vol.5, Iss.4, 2011-11, pp. : 299-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pricing and reimbursement of drugs in Ireland

By Barry Michael   Tilson Lesley   Ryan Máirín  

The European Journal of Health Economics, Vol. 5, Iss. 2, 2004-05 ,pp. : 190-194

Springer Publishing Company

Access to resources Recommend Favorite

Pricing and reimbursement of pharmaceuticals in Italy

By Folino-Gallo Pietro  

The European Journal of Health Economics, Vol. 9, Iss. 3, 2008-08 ,pp. : 305-310

Springer Publishing Company

Access to resources Recommend Favorite

The Challenges of Orphan Drugs and Orphan Diseases: Real and Imagined

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 151-153

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of relative effectiveness information in reimbursement and pricing decisions in Europe

By van Nooten Floortje   Caro J Jaime  

Journal of Comparative Effectiveness Research, Vol. 2, Iss. 1, 2013-01 ,pp. : 33-44

Future Medicine

Access to resources Recommend Favorite

PRICING, REIMBURSEMENT, AND HEALTH TECHNOLOGY ASSESSMENT OF MEDICINAL PRODUCTS IN BULGARIA

By  

International Journal of Technology Assessment in Health Care, Vol. 33, Iss. 3, 2017-08 ,pp. : 365-370

Cambridge University Press

Access to resources Recommend Favorite